Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Insights into antitrypanosomal drug mode-of-action from cytology-based profiling
J. Alero Thomas, Nicola Baker, Sebastian Hutchinson, et al.
PLoS neglected tropical diseases (2018) Vol. 12, Iss. 11, pp. e0006980-e0006980
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

An Overview of Drug Resistance in Protozoal Diseases
Rita Capela, Rui Moreira, Francisca Lopes
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 22, pp. 5748-5748
Open Access | Times Cited: 158
100 Years of Suramin
Natalie Wiedemar, Dennis A. Hauser, Pascal Mäser
Antimicrobial Agents and Chemotherapy (2019) Vol. 64, Iss. 3
Open Access | Times Cited: 156
Transforming the chemotherapy of human African trypanosomiasis
Michael P. Barrett
Clinical Microbiology Reviews (2025)
Closed Access | Times Cited: 2
New Drugs for Human African Trypanosomiasis: A Twenty First Century Success Story
Emily A. Dickie, Federica Giordani, Matthew K. Gould, et al.
Tropical Medicine and Infectious Disease (2020) Vol. 5, Iss. 1, pp. 29-29
Open Access | Times Cited: 117
Polyamine metabolism links gut microbiota and testicular dysfunction
Qi Zhao, Jian‐Feng Huang, Yan Cheng, et al.
Microbiome (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 70
An Update on African Trypanocide Pharmaceutics and Resistance
Keneth Iceland Kasozi, Ewan T. MacLeod, Ibrahim Ntulume, et al.
Frontiers in Veterinary Science (2022) Vol. 9
Open Access | Times Cited: 59
Current Treatments to Control African Trypanosomiasis and One Health Perspective
Alberto Venturelli, Lorenzo Tagliazucchi, Clara Lima, et al.
Microorganisms (2022) Vol. 10, Iss. 7, pp. 1298-1298
Open Access | Times Cited: 48
Human African Trypanosomiasis (sleeping sickness): Current knowledge and future challenges
Roberta Papagni, Roberta Novara, Maria Letizia Minardi, et al.
Frontiers in Tropical Diseases (2023) Vol. 4
Open Access | Times Cited: 30
Drug resistance in animal trypanosomiases: Epidemiology, mechanisms and control strategies
Marzuq A. Ungogo, Harry P. de Koning
International Journal for Parasitology Drugs and Drug Resistance (2024) Vol. 25, pp. 100533-100533
Open Access | Times Cited: 13
Antimicrobials and resistance part II: Antifungals, antivirals, and antiparasitics
Fiorinda F. Muhaj, Saira George, Celine Nguyen, et al.
Journal of the American Academy of Dermatology (2022) Vol. 86, Iss. 6, pp. 1207-1226
Closed Access | Times Cited: 33
Tackling Sleeping Sickness: Current and Promising Therapeutics and Treatment Strategies
Miebaka Jamabo, Maduma Ernst Mahlalela, Adrienne L. Edkins, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12529-12529
Open Access | Times Cited: 17
Suramin exposure alters cellular metabolism and mitochondrial energy production in African trypanosomes
Martin Zoltner, Gustavo D. Campagnaro, Gergana Taleva, et al.
Journal of Biological Chemistry (2020) Vol. 295, Iss. 24, pp. 8331-8347
Open Access | Times Cited: 38
Of Drugs and Trypanosomatids: New Tools and Knowledge to Reduce Bottlenecks in Drug Discovery
Arijit Bhattacharya, Audrey Corbeil, Rubens Lima do Monte‐Neto, et al.
Genes (2020) Vol. 11, Iss. 7, pp. 722-722
Open Access | Times Cited: 37
Structure of trypanosome coat protein VSGsur and function in suramin resistance
Johan Zeelen, Monique van Straaten, Joseph Verdi, et al.
Nature Microbiology (2021) Vol. 6, Iss. 3, pp. 392-400
Open Access | Times Cited: 28
Cloning and Characterization of Trypanosoma congolense and T. vivax Nucleoside Transporters Reveal the Potential of P1-Type Carriers for the Discovery of Broad-Spectrum Nucleoside-Based Therapeutics against Animal African Trypanosomiasis
Marzuq A. Ungogo, Mustafa M. Aldfer, Manal J. Natto, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3144-3144
Open Access | Times Cited: 12
Cytological profiling of trypanocidal principles from Aloe barbadensis and Taraxacum officinale
Pearl Ihuoma Akazue, Neils B. Quashie, Dorcas Osei‐Safo, et al.
Phytomedicine Plus (2025), pp. 100793-100793
Open Access
Drug Resistance in Animal Trypanosomiases: Epidemiology, Mechanisms and Control Strategies
Marzuq A. Ungogo, Harry P. de Koning
(2024)
Open Access | Times Cited: 3
Pentamidine inhibits prostate cancer progression via selectively inducing mitochondrial DNA depletion and dysfunction
Lin Liu, Fan Wang, Tong Yu, et al.
Cell Proliferation (2019) Vol. 53, Iss. 1
Open Access | Times Cited: 23
Nano-Leish-IL: A novel iron oxide-based nanocomposite drug platform for effective treatment of cutaneous leishmaniasis
Sriram Kannan, Yifat Harel, Esthy Levy, et al.
Journal of Controlled Release (2021) Vol. 335, pp. 203-215
Closed Access | Times Cited: 17
Nanotechnological interventions for treatment of trypanosomiasis in humans and animals
Kedar S. Prayag, Dhanashree H. Surve, Atish T. Paul, et al.
Drug Delivery and Translational Research (2020) Vol. 10, Iss. 4, pp. 945-961
Closed Access | Times Cited: 18
Antiprotozoal agents: How have they changed over a decade?
Vitória de Souza Fernandes, Rafael da Rosa, Lara Almida Zimmermann, et al.
Archiv der Pharmazie (2021) Vol. 355, Iss. 2
Closed Access | Times Cited: 15
Preliminary Structure–Activity Relationship Study of the MMV Pathogen Box Compound MMV675968 (2,4-Diaminoquinazoline) Unveils Novel Inhibitors of Trypanosoma brucei brucei
Darline Dize, Rolland Bantar Tata, Rodrigue Keumoe, et al.
Molecules (2022) Vol. 27, Iss. 19, pp. 6574-6574
Open Access | Times Cited: 10
Human African Trypanosomiasis (Sleeping Sickness)
C. Burri, Srinivasa P. S. Rao, Suresh B. Lakshminarayana, et al.
MDPI eBooks (2020)
Open Access | Times Cited: 15
Sustainable Elimination (Zero Cases) of Sleeping Sickness: How Far Are We from Achieving This Goal?
Pearl Ihuoma Akazue, Godwin U. Ebiloma, Olumide Ajibola, et al.
Pathogens (2019) Vol. 8, Iss. 3, pp. 135-135
Open Access | Times Cited: 14
Suramin action in African trypanosomes involves a RuvB-like DNA helicase
Anna Albisetti, Silvan Hälg, Martin Zoltner, et al.
International Journal for Parasitology Drugs and Drug Resistance (2023) Vol. 23, pp. 44-53
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top